![Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA](https://primarycareipa.org/wp-content/uploads/2020/11/pt-chart1.38_1.jpg)
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA
American Diabetes Association - Professional Publications - A new ADA-EASD Consensus Report calls for a paradigm shift in management to a patient-centered approach with shared decision making. It provides a comprehensive review
![2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-019-05039-w/MediaObjects/125_2019_5039_Fig2_HTML.png)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![Summary of the overall approach to glucose-lowering medications in type... | Download Scientific Diagram Summary of the overall approach to glucose-lowering medications in type... | Download Scientific Diagram](https://www.researchgate.net/publication/336561025/figure/fig1/AS:814252587745281@1571144353530/Summary-of-the-overall-approach-to-glucose-lowering-medications-in-type-2-diabetes-as.png)
Summary of the overall approach to glucose-lowering medications in type... | Download Scientific Diagram
![JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes](https://www.mdpi.com/jcm/jcm-09-00912/article_deploy/html/images/jcm-09-00912-g001-550.jpg)
JCM | Free Full-Text | Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
![From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01281-y/MediaObjects/12933_2021_1281_Fig3_HTML.png)
From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text
![Edgar V. Lerma 🇵🇭 on X: "Glucose lowering medications in Type 2 Diabetes ca. 2019 #Nephpearls https://t.co/JfHQk8LVyB" / X Edgar V. Lerma 🇵🇭 on X: "Glucose lowering medications in Type 2 Diabetes ca. 2019 #Nephpearls https://t.co/JfHQk8LVyB" / X](https://pbs.twimg.com/media/EbIha2bWkAAlUI0.jpg:large)